According to Szu et al., upregulation of OLIG2 is characteristic of glioma cells and is associated with their high proliferative potential, and pharmacological inhibition of OLIG2 significantly improved the survival of mice with high-grade glioma and medulloblastoma (Szu et al., 2023). Here, OLIG2 is linked to central nervous system cancer.